T. Lo

Jan 15, 2025 | jdsupra.com | Austin Chambers |Justin Huff |T. Lo

The U.S. Department of Justice (“DOJ”) published its final rule (“Final Rule”) on January 8, 2025, that will prohibit or restrict transfer of certain data of U.S. persons to countries of concern, including to China. The Final Rule largely tracks with DOJ’s notice of proposed rulemaking (“Proposed Rule”), which we summarized in a previous eUpdate.

Dec 10, 2024 | jdsupra.com | Nelson Dong |Justin Huff |T. Lo

On December 2, 2024, the U.S. Department of Commerce’s Bureau of Industry and Security (“BIS”) adopted yet another round of amendments to the Export Administration Regulations (“EAR”) to curb advances by the People’s Republic of China (“PRC”) in artificial intelligence (“AI”) and advanced semiconductor design and production.[1] These EAR amendments aim to impede China’s ability to develop an indigenous semiconductor manufacturing base and to prevent the PRC from applying such key technologies...

Nov 1, 2024 | jdsupra.com | Austin Chambers |Justin Huff |T. Lo

The U.S. Department of Justice (“DOJ”) released a Notice of Proposed Rulemaking (“Proposed Rule”) on October 21 that would prohibit or restrict the transfer of certain data of U.S. persons to China and other countries of concern. Companies involved in cross-border transactions or with operations involving processing of personal data of U.S. persons with any nexus to a country of concern should carefully review the Proposed Rule.

Oct 3, 2024 | jdsupra.com | Nelson Dong |Justin Huff |T. Lo

In a notice published on September 9, 2024, announcing a proposed rule and request for comment (“Proposed Rule”), the U.S. Department of Commerce called for new reporting requirements for the development of certain advanced artificial intelligence (“AI”) dual-use foundation models and computing clusters used to train such AI models.

Sep 18, 2024 | jdsupra.com | Nelson Dong |Justin Huff |T. Lo

On Friday, September 13, 2024, the Office of the United States Trade Representative (“USTR”) announced its final modifications to the Section 301 tariffs on Chinese-origin goods. USTR will keep all of the proposed tariff increases, including higher tariffs on many categories of medical products. Most of these tariff increases are to take effect on September 27, 2024, but some increases will be deferred until January 1, 2025, or January 1, 2026.